Highly significant antitumour activity was observed in all of the vandetanib-treated animals, whereas tumours in vehicle-treated rats progressed ( Figure 3B ).
← all excerpts
False-negative MRI biomarkers of tumour response to targeted cancer therapeutics.
1
—
—